CON
CON
Concentra Group Holdings Parent, Inc.Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q4-2025 | $539.1M ▼ | $-1.68B ▼ | $36.13M ▼ | 6.7% ▼ | $0.29 ▼ | $89.96M ▼ |
| Q3-2025 | $572.8M ▲ | $72.79M ▲ | $48.26M ▲ | 8.43% ▲ | $0.38 ▲ | $114.38M ▲ |
| Q2-2025 | $550.78M ▲ | $71.91M ▲ | $44.56M ▲ | 8.09% ▲ | $0.35 ▲ | $108.54M ▲ |
| Q1-2025 | $500.75M ▲ | $63.33M ▲ | $38.91M ▲ | 7.77% ▲ | $0.31 ▲ | $96.06M ▲ |
| Q4-2024 | $465.04M | $61.1M | $21.51M | 4.63% | $0.17 | $74.7M |
What's going well?
The company remains profitable and overhead costs are under control. There were no unusual charges or one-time items distorting results.
What's concerning?
Revenue is down, margins are under pressure, and profits dropped sharply. High interest costs are a persistent drag, and expenses aren't falling fast enough to match lower sales.
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q4-2025 | $79.9M ▲ | $2.86B ▲ | $2.44B ▲ | $393.28M ▲ |
| Q3-2025 | $49.94M ▼ | $2.84B ▲ | $2.43B ▼ | $385.49M ▲ |
| Q2-2025 | $73.87M ▲ | $2.84B ▲ | $2.47B ▲ | $342.64M ▲ |
| Q1-2025 | $52.11M ▼ | $2.73B ▲ | $2.4B ▼ | $307.12M ▲ |
| Q4-2024 | $183.25M | $2.7B | $2.4B | $275.67M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q4-2025 | $39.34M ▼ | $118.69M ▲ | $-20.13M ▲ | $-68.6M ▼ | $29.96M ▲ | $180.86M ▲ |
| Q3-2025 | $48.26M ▲ | $60.63M ▼ | $-20.47M ▲ | $-64.09M ▼ | $-23.93M ▼ | $39.42M ▼ |
| Q2-2025 | $44.56M ▲ | $88.38M ▲ | $-79.51M ▲ | $12.89M ▼ | $21.76M ▲ | $63.15M ▲ |
| Q1-2025 | $40.64M ▲ | $11.7M ▼ | $-294.75M ▼ | $151.9M ▲ | $-131.15M ▼ | $-4.03M ▼ |
| Q4-2024 | $22.8M | $93.71M | $-16.69M | $-30.59M | $46.43M | $77.03M |
What's strong about this company's cash flow?
Cash from operations nearly doubled and free cash flow soared to $181 million. The company is paying down debt, growing its cash pile, and easily covering dividends.
What are the cash flow concerns?
A big part of the cash surge came from stretching payables and slower customer payments, which may not be repeatable. Net income actually fell, and receivables are building up.
Q4 2025 Earnings Call Summary
Read Call Summary5-Year Trend Analysis
A comprehensive look at Concentra Group Holdings Parent, Inc.'s financial evolution and strategic trajectory over the past five years.
Concentra’s key strengths are a leading market position in occupational health, a large and integrated network of clinics and onsite facilities, and a strong history of cash generation from operations. Its margins and efficiency metrics up to 2024 show a well-run, profitable service model, supported by disciplined overhead control. The company has also developed meaningful technology capabilities—telemedicine, employer portals, and analytics—that enhance its value proposition to large employers and deepen client relationships. Short‑term liquidity is solid, with a stronger cash position and sufficient current assets to cover near‑term obligations.
The main risks sit on the balance sheet and in recent financial behavior. Debt levels have risen sharply, equity has been heavily reduced, and retained earnings have been drawn down, likely tied to large shareholder distributions and recapitalization moves. This significantly increases financial leverage and leaves less room to absorb shocks. The 2025 income statement and cash‑flow anomalies—no revenue, no capex, profits driven by non‑operating items—raise questions about the underlying continuity of the business and the sustainability of reported numbers. Strategically, the company faces competition from both traditional healthcare providers and tech‑enabled entrants, along with regulatory uncertainty and labor cost pressures.
Looking forward, the core occupational health franchise and cash‑generating ability observed through 2024 provide a solid base, assuming the underlying business has not been fundamentally altered by recent events. The company appears well positioned to benefit from trends such as employers’ focus on worker safety, productivity, and convenient access to care, especially as telehealth and onsite models become more embedded. However, the highly leveraged capital structure, unusual recent results, and potential underinvestment in physical assets introduce more uncertainty into the long‑term picture. The trajectory from here will depend heavily on how management balances debt, capital returns, reinvestment in the network and technology, and the ability to maintain its competitive edge in an evolving healthcare landscape.
About Concentra Group Holdings Parent, Inc.
https://www.concentra.comConcentra Group Holdings Parent, Inc. provides occupational health services in the United States. The company offers occupational and consumer health services, including workers' compensation injury care, urgent care, clinical testing, preventative care, and employer services, as well as wellness programs through occupational health centers and onsite clinics.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q4-2025 | $539.1M ▼ | $-1.68B ▼ | $36.13M ▼ | 6.7% ▼ | $0.29 ▼ | $89.96M ▼ |
| Q3-2025 | $572.8M ▲ | $72.79M ▲ | $48.26M ▲ | 8.43% ▲ | $0.38 ▲ | $114.38M ▲ |
| Q2-2025 | $550.78M ▲ | $71.91M ▲ | $44.56M ▲ | 8.09% ▲ | $0.35 ▲ | $108.54M ▲ |
| Q1-2025 | $500.75M ▲ | $63.33M ▲ | $38.91M ▲ | 7.77% ▲ | $0.31 ▲ | $96.06M ▲ |
| Q4-2024 | $465.04M | $61.1M | $21.51M | 4.63% | $0.17 | $74.7M |
What's going well?
The company remains profitable and overhead costs are under control. There were no unusual charges or one-time items distorting results.
What's concerning?
Revenue is down, margins are under pressure, and profits dropped sharply. High interest costs are a persistent drag, and expenses aren't falling fast enough to match lower sales.
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q4-2025 | $79.9M ▲ | $2.86B ▲ | $2.44B ▲ | $393.28M ▲ |
| Q3-2025 | $49.94M ▼ | $2.84B ▲ | $2.43B ▼ | $385.49M ▲ |
| Q2-2025 | $73.87M ▲ | $2.84B ▲ | $2.47B ▲ | $342.64M ▲ |
| Q1-2025 | $52.11M ▼ | $2.73B ▲ | $2.4B ▼ | $307.12M ▲ |
| Q4-2024 | $183.25M | $2.7B | $2.4B | $275.67M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q4-2025 | $39.34M ▼ | $118.69M ▲ | $-20.13M ▲ | $-68.6M ▼ | $29.96M ▲ | $180.86M ▲ |
| Q3-2025 | $48.26M ▲ | $60.63M ▼ | $-20.47M ▲ | $-64.09M ▼ | $-23.93M ▼ | $39.42M ▼ |
| Q2-2025 | $44.56M ▲ | $88.38M ▲ | $-79.51M ▲ | $12.89M ▼ | $21.76M ▲ | $63.15M ▲ |
| Q1-2025 | $40.64M ▲ | $11.7M ▼ | $-294.75M ▼ | $151.9M ▲ | $-131.15M ▼ | $-4.03M ▼ |
| Q4-2024 | $22.8M | $93.71M | $-16.69M | $-30.59M | $46.43M | $77.03M |
What's strong about this company's cash flow?
Cash from operations nearly doubled and free cash flow soared to $181 million. The company is paying down debt, growing its cash pile, and easily covering dividends.
What are the cash flow concerns?
A big part of the cash surge came from stretching payables and slower customer payments, which may not be repeatable. Net income actually fell, and receivables are building up.
Q4 2025 Earnings Call Summary
Read Call Summary5-Year Trend Analysis
A comprehensive look at Concentra Group Holdings Parent, Inc.'s financial evolution and strategic trajectory over the past five years.
Concentra’s key strengths are a leading market position in occupational health, a large and integrated network of clinics and onsite facilities, and a strong history of cash generation from operations. Its margins and efficiency metrics up to 2024 show a well-run, profitable service model, supported by disciplined overhead control. The company has also developed meaningful technology capabilities—telemedicine, employer portals, and analytics—that enhance its value proposition to large employers and deepen client relationships. Short‑term liquidity is solid, with a stronger cash position and sufficient current assets to cover near‑term obligations.
The main risks sit on the balance sheet and in recent financial behavior. Debt levels have risen sharply, equity has been heavily reduced, and retained earnings have been drawn down, likely tied to large shareholder distributions and recapitalization moves. This significantly increases financial leverage and leaves less room to absorb shocks. The 2025 income statement and cash‑flow anomalies—no revenue, no capex, profits driven by non‑operating items—raise questions about the underlying continuity of the business and the sustainability of reported numbers. Strategically, the company faces competition from both traditional healthcare providers and tech‑enabled entrants, along with regulatory uncertainty and labor cost pressures.
Looking forward, the core occupational health franchise and cash‑generating ability observed through 2024 provide a solid base, assuming the underlying business has not been fundamentally altered by recent events. The company appears well positioned to benefit from trends such as employers’ focus on worker safety, productivity, and convenient access to care, especially as telehealth and onsite models become more embedded. However, the highly leveraged capital structure, unusual recent results, and potential underinvestment in physical assets introduce more uncertainty into the long‑term picture. The trajectory from here will depend heavily on how management balances debt, capital returns, reinvestment in the network and technology, and the ability to maintain its competitive edge in an evolving healthcare landscape.

CEO
William Keith Newton
Compensation Summary
(Year 2024)
Upcoming Earnings
ETFs Holding This Stock
Summary
Showing Top 3 of 181
Ratings Snapshot
Rating : B+
Most Recent Analyst Grades
Grade Summary
Showing Top 3 of 3
Price Target
Institutional Ownership
BLACKROCK, INC.
Shares:17.33M
Value:$415.34M
PRICE T ROWE ASSOCIATES INC /MD/
Shares:17.17M
Value:$411.32M
VANGUARD GROUP INC
Shares:13.21M
Value:$316.4M
Summary
Showing Top 3 of 295

